Roche, Biogen report one death in MS drug trial

Discuss Ocrelizumab, a monoclonal antibody treatment for MS.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

Roche, Biogen report one death in MS drug trial

Post by MSUK »

Image

Roche Holding AG and Biogen Idec Inc reported data from a mid-stage trial of their experimental multiple sclerosis drug ocrelizumab on Friday that showed one patient died of an inflammatory condition.

Data presented at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) showed that the drug reduced disease activity by a significant amount as measured by the number of brain lesions and relapse rate. But some side effects were greater in the ocrelizumab arm than in the placebo arm.

In May, Roche of Switzerland and Biogen of Cambridge, Massachusetts, said they would discontinue studies of the drug as a treatment for rheumatoid arthritis after a safety monitoring board ruled that the risk outweighed the benefit in the RA population.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1397
MS-UK - http://www.ms-uk.org/
User avatar
whyRwehere
Family Elder
Posts: 917
Joined: Mon Oct 03, 2005 2:00 pm
Contact:

Post by whyRwehere »

oh, too risky for those arthritis patients, let's give it to the desperate MS ones... :evil:
User avatar
CCSVIhusband
Family Elder
Posts: 475
Joined: Sun Jun 27, 2010 2:00 pm
Location: Pittsburgh, PA USA
Contact:

Post by CCSVIhusband »

WHOA! EVERY neurologist better come out against this drug now ... it's now as bad as CCSVI ...

STOP EVERYTHING!
User avatar
rainer
Family Elder
Posts: 367
Joined: Thu Jan 17, 2008 3:00 pm

Post by rainer »

I wonder how they studied anything before god's gift of CCSVI came down from the heavens to show science the platonic state of medical perfection. :roll:
Post Reply
  • Similar Topics
    Replies
    Views
    Last post

Return to “Ocrevus (Ocrelizumab)”